These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9284792)

  • 1. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Mitchell SM; Youle MS; Membrey WL; Jones CD
    Lancet; 1997 Aug; 350(9077):588; author reply 590. PubMed ID: 9284792
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uthayakumar S; Birthistle K; Dalton R; Hay PE
    Lancet; 1997 Aug; 350(9077):588-9; author reply 590. PubMed ID: 9284793
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A; Cooper DA
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB; Goldberg B
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapse of CMV retinitis in an AIDS patient with high CD4 counts.
    Petit N; Zandotti C; Riss JM; Frippiat F; Moulin JF; Gastaut JA
    J Antimicrob Chemother; 1998 Jun; 41(6):666-7. PubMed ID: 9687110
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune recovery vitritis in HIV infection: abstracts and commentary.
    Dunn JP
    JAMA; 1998 Jul; 280(2):185-6. PubMed ID: 9669796
    [No Abstract]   [Full Text] [Related]  

  • 8. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
    J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I; Ries E; Krepler K; Derbolav A; Rieger A; Armbruster C; Wedrich A
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
    Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan; 77(1):3. PubMed ID: 10654853
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC; Benson CA; Johnson DW; Weinberg A
    Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
    Jacobson MA; Bredt BM
    J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
    van den Horn GJ; Meenken C; Danner SA; Reiss P; de Smet MD
    Br J Ophthalmol; 1998 Sep; 82(9):988-90. PubMed ID: 9893585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.
    Jabs DA
    Br J Ophthalmol; 2001 Apr; 85(4):381-2. PubMed ID: 11264121
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.
    Price P; Mathiot N; Krueger R; Stone S; Keane NM; French MA
    J Clin Virol; 2001 Oct; 22(3):279-87. PubMed ID: 11564593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.